OXiGENE ( $OXGN ) reports cash of approximately $8.5 million
As of July 8, 2011, shares of common stock in an aggregate offering amount of $19,156,051 have been sold under the July 21, 2010, January 1, 2011, June 1, 2011, and June 29, 2011 prospectus supplements, and no further sales of shares will be made under such prospectus supplements. Sales of common stock under the July 8, 2011 prospectus supplement will be made from time to time as market conditions warrant, in the Company's discretion.
The Agreement has been previously filed as Exhibit 10.1 to our Current Report on Form 8-K on July 21, 2010 and is incorporated herein by reference. A copy of the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., relating to the legality of the shares, is filed as Exhibit 5.1 to this Current Report and is incorporated by reference into the registration statement. As of June 30, 2011, OXiGENE expects to report cash, cash equivalents and restricted cash of approximately $8.5 million, compared with approximately $2.7 million at March 31, 2011.
Source: http://www.dailyfinance.com/company/oxigene-inc/...18/pdf/sec-filings |